3i, LP 13D and 13G filings for Chromocell Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:05 pm Sale | 2024-09-30 | 13G | Chromocell Therapeutics Corporation CHRO | 3i, LP | 301,000 4.990% | -17,823 (-5.59%) | Filing |
| 2024-03-01 5:07 pm Purchase | 2024-02-21 | 13G | Chromocell Therapeutics Corporation CHRO | 3i, LP | 318,823 5.500% | 318,823 (New Position) | Filing |